Stockscreener 앱 받기
0.49
2.91%
-0.0147
시간 외 거래:
.49
Femasys Inc 주식(FEMY)의 최신 뉴스
Forecast Cut: What dividend growth rate does Femasys Inc offerMarket Risk Summary & Safe Investment Capital Preservation Plans - baoquankhu1.vn
Femasys expands European presence with Swiss distribution deal By Investing.com - Investing.com Nigeria
Femasys Inc. Expands European Commercial Footprint with Swiss Partner for FemBloc, FemaSeed, and Portfolio Products - marketscreener.com
Femasys stock rises on new distribution partnership in Switzerland By Investing.com - Investing.com Australia
Femasys stock rises on new distribution partnership in Switzerland - Investing.com
Femasys expands European presence with Swiss distribution deal - Investing.com
Femasys Expands European Commercial Footprint with Swiss Partner for FemBloc, FemaSeed, and Portfolio Products - The Manila Times
Femasys Inc. Expands European Presence with New Distribution Partnership in Switzerland - Quiver Quantitative
New Swiss deal expands access to permanent birth control and fertility care - Stock Titan
Insider Sell: Is Omega Healthcare Investors Inc subject to activist investor interest2025 Major Catalysts & Smart Investment Allocation Tips - baoquankhu1.vn
Trading Action: Can Femasys Inc sustain its profitabilityTake Profit & Accurate Entry/Exit Alerts - baoquankhu1.vn
Femasys Secures Major Order for FemBloc Launch - MSN
Travel Stocks: What is PCARs revenue forecastEarnings Trend Report & Free Fast Entry Momentum Trade Alerts - baoquankhu1.vn
Returns Recap: Does Ares Management Corporation meet Warren Buffetts criteria2025 Earnings Impact & Growth Oriented Trading Recommendations - baoquankhu1.vn
Femasys Receives Nasdaq Extension to Regain Listing Compliance - The Globe and Mail
Femasys granted 180-day extension by Nasdaq to meet minimum bid price rule - Investing.com
Femasys Disclosed Failure to Satisfy a Continued Listing Rule or Standard - TradingView
Stock Recap: Will FUFU benefit from geopolitical trendsCPI Data & Fast Entry Momentum Trade Alerts - baoquankhu1.vn
Femasys Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Price Requirement - Sahm
Femasys receives 180-day Nasdaq extension to meet minimum bid price - Investing.com Nigeria
Femasys secures Nasdaq extension to regain bid price compliance - MSN
Femasys Granted 180-Day Extension By Nasdaq To Regain Compliance With Minimum Bid Price Requirement - TradingView
Nasdaq gives Femasys more time to fix sub-$1 share price by July 2026 - Stock Titan
Femasys partners with Refuah Health Center to expand FemaSeed fertility treatment - Investing.com Nigeria
Dow Update: Why Femasys Inc stock attracts global investorsTrade Volume Summary & AI Forecast Swing Trade Picks - Bộ Nội Vụ
Femasys partners with Refuah Health Center to expand FemaSeed fertility treatment By Investing.com - Investing.com South Africa
Femasys Inc. Announces Partnership with Refuah Health Center to Expand First-Line Access to FemaSeed®? in Community-Based Care - marketscreener.com
Femasys Inc. Partners with Refuah Health Center to Enhance Accessibility of FemaSeed for Infertility Treatment - Quiver Quantitative
Femasys Announces Partnership with Refuah Health Center to Expand First-Line Access to FemaSeed® in Community-Based Care - The Manila Times
Will Femasys Inc. stock maintain growth storyGap Up & Reliable Breakout Stock Forecasts - ulpravda.ru
What valuation multiples suggest for Femasys Inc. stockJuly 2025 Update & Safe Capital Growth Stock Tips - Улправда
Published on: 2026-01-09 05:32:45 - Улправда
Can Femasys Inc. stock rebound after recent weaknessPortfolio Return Report & Expert Approved Trade Ideas - Улправда
How Femasys Inc. stock performs after earnings2025 Price Momentum & Weekly High Momentum Picks - Улправда
Jonathan Schechter buys PharmaCyte Biotech shares worth $48,232 By Investing.com - Investing.com Nigeria
How Femasys Inc. stock reacts to inflationary pressures2026 world cup usa national team group stage goalkeepers counter attacking expert forecast guide - ulpravda.ru
Earnings Beat: Will MARZ stock keep high P E multiples2025 Biggest Moves & Pattern Based Trade Signal System - moha.gov.vn
Femasys gains UK approval for women's health products - MSN
Market Leaders: How strong is Femasys Inc stock balance sheetQuarterly Earnings Summary & AI Forecast for Swing Trade Picks - Bộ Nội Vụ
User | theeveningleader.comFemasys Inc.Common Stock (Nasdaq:FEMY) Stock Quote - FinancialContent
Femasys files for at-the-market offering of up to $9.8 million in common stock - Investing.com India
Femasys Launches At-the-Market Common Stock Offering - TipRanks
Femasys files for at-the-market offering of up to $9.8 million in common stock By Investing.com - Investing.com South Africa
Femasys Stock Drop Looks Sharp, But How Deep Can It Go? - Trefis
Suwanee company Femasys Inc. gets FDA approval for diagnostic device - The Business Journals
6.80%
자본화:
|
볼륨(24시간):